Clinical Trial Update: Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for the Selegiline Transdermal System in cocaine dependence. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cocaine-related Disorders

Drugs mentioned

• Selegiline transdermal system (selegiline)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Cocaine-Related Disorders | Phase 3 | Status: COMPLETED